v3.7.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2017
Mar. 31, 2017
Current assets    
Cash $ 327,206 $ 1,559,701
Prepaid expenses and other current assets 38,450 37,551
Total current assets 365,656 1,597,252
Property and equipment, net 45,893 29,223
Patents and patents pending, net 82,705 84,996
Deposits 14,897 14,897
Total assets 509,151 1,726,368
Current liabilties    
Accounts payable 277,094 484,423
Due to related parties 48,366 57,866
Other current liabilities 82,845 69,467
Total current liabilities 408,305 611,756
Convertible notes payable, net 1,050,911 519,200
Total liabilities 1,459,216 1,130,956
Stockholders' (Deficit) Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized as of June 30, 2017 and March 31, 2017; 8,869,571 and 8,797,086 shares issued and outstanding as of June 30, 2017 and March 31, 2017, respectively 8,869 8,796
Additional paid-in capital 94,745,740 94,445,739
Accumulated deficit (95,619,939) (93,778,156)
Total Aethlon Medical, Inc. stockholders' (deficit) equity before noncontrolling interests (865,330) 676,379
Noncontrolling interests (84,735) (80,967)
Total stockholders' (deficit) equity (950,065) 595,412
Total liabilities and stockholders' (deficit) equity $ 509,151 $ 1,726,368

Source